Your browser doesn't support javascript.
loading
Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine.
Quinn, Bridget A; Wang, Si; Barile, Elisa; Das, Swadesh K; Emdad, Luni; Sarkar, Devanand; De, Surya K; Morvaridi, Susan Kharagh; Stebbins, John L; Pandol, Stephen J; Fisher, Paul B; Pellecchia, Maurizio.
Afiliación
  • Quinn BA; Department of Human and Molecular Genetics, VCU Institute of Molecular Medicine and VCU Massey Cancer Center, Virginia Commonwealth University, School of Medicine, Richmond, VA 23298, USA.
  • Wang S; Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
  • Barile E; Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
  • Das SK; Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA 92521, USA.
  • Emdad L; Department of Human and Molecular Genetics, VCU Institute of Molecular Medicine and VCU Massey Cancer Center, Virginia Commonwealth University, School of Medicine, Richmond, VA 23298, USA.
  • Sarkar D; Department of Human and Molecular Genetics, VCU Institute of Molecular Medicine and VCU Massey Cancer Center, Virginia Commonwealth University, School of Medicine, Richmond, VA 23298, USA.
  • De SK; Department of Human and Molecular Genetics, VCU Institute of Molecular Medicine and VCU Massey Cancer Center, Virginia Commonwealth University, School of Medicine, Richmond, VA 23298, USA.
  • Morvaridi SK; Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
  • Stebbins JL; Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA 92521, USA.
  • Pandol SJ; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Fisher PB; Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
  • Pellecchia M; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Oncotarget ; 7(13): 17103-10, 2016 Mar 29.
Article en En | MEDLINE | ID: mdl-26959746

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Receptor EphA2 / Desoxicitidina / Terapia Molecular Dirigida / Antimetabolitos Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Receptor EphA2 / Desoxicitidina / Terapia Molecular Dirigida / Antimetabolitos Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos